RIAD, Abanoub, Islam KASSEM, Mai BADRAH a Miloslav KLUGAR. The manifestation of oral mucositis in COVID-19 patients: A case-series. Dermatologic Therapy. Hoboken: Wiley, 2020, roč. 33, č. 6, s. 1-3. ISSN 1396-0296. Dostupné z: https://dx.doi.org/10.1111/dth.14479.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název The manifestation of oral mucositis in COVID-19 patients: A case-series
Autoři RIAD, Abanoub (818 Egypt, garant, domácí), Islam KASSEM (818 Egypt), Mai BADRAH (818 Egypt) a Miloslav KLUGAR (203 Česká republika, domácí).
Vydání Dermatologic Therapy, Hoboken, Wiley, 2020, 1396-0296.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30216 Dermatology and venereal diseases
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 2.851
Kód RIV RIV/00216224:14110/20:00116797
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1111/dth.14479
UT WoS 000587315600001
Klíčová slova anglicky Oral Mucositis; COVID-19
Štítky 14119612, 14119613, rivok
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 13. 1. 2021 13:39.
Anotace
We have read with great interest the correspondence of Kahraman et al (2020) on the emergence of oral mucosal changes adjacent to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; hereby we demonstrate the characteristics of 13 laboratoryconfirmed coronavirus disease (COVID-19) patients with oral mucositis according to the CARE guidelines. The referenced patients sought care at our department from April to August 2020 due to generalized pain and soreness within the oral cavity related mainly to nonkeratinized mucosa without a specific cause (Table 1). All included patients had previously undergone polymerase chain reaction (PCR) testing for SARS-CoV-2, which confirmed their infection with a mean cycle threshold (Ct) value of 18.46 ± 3.8 (12-26). Their mean age was 51.08 ± 8.79 (34-62) years old, and eight of them (62.5%) were females. Regarding their COVID-19 symptoms, two patients (15.4%) had persistent fever, four (30.8%) had ageusia, and two (15.4%) had anosmia. The majority of them (69.2%) had a mild course of SARS-CoV-2 infection and were prescribed paracetamol (PCM); contrarily, four patients experienced a moderate course of infection—two patients (15.4%) were prescribed chloroquine and other two (15.4%) were prescribed dexamethasone.
VytisknoutZobrazeno: 14. 5. 2024 00:58